The Maureen and Mike Mansfield Foundation is pleased to announce the selection of the ninth cohort of the Mansfield-PhRMA Research Scholars Program. This international exchange and professional development opportunity brings young pharmaceutical researchers from Japan to the U.S. to learn about translational research, healthcare policy, and regulatory practices through site visits in Washington, D.C., Philadelphia, and Boston. The ninth cohort will participate in a two-week study tour in September 2023.
The 2023 Mansfield-PhRMA program will include eight researchers from Japan’s pharmaceutical research community and three observers from the Japan Agency for Medical Research and Development (AMED), the Pharmaceutical and Medical Devices Agency (PMDA) and the Ministry of Economy, Trade and Industry (METI). This program was launched in 2013 and is sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA).
The ninth cohort of the Mansfield-PhRMA Research Scholars Program includes:
- Asumi Iesato, Clinical Research Fellow, Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research
- Mitsuho Imai, Medical Oncologist, Translational Research Support Office, International Research Promotion Office; Drug Development Promotion Department, Genetic Medicine Department, National Cancer Center Hospital East
- Mamoru Ogawa, Ophthalmologist, Department of Ophthalmology, Keio University School of Medicine
- Yukinori Ozaki, Chief physician, Breast Medical Oncology, Advanced Medical Development Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research
- Tomoya Kurokawa, Assistant professor, Clinical Research Center, Chiba University Hospital
- Tatsunori Shimoi, Head of Physician, Department of Medical Oncology, Director of International Medical Care Section, Department of International Clinical Development, National Cancer Center Hospital
- Hiroya Tamai, Project Assistant Professor, Division of Rheumatology, Department of Internal Medicine / Clinical and Translational Research Center, Keio University Hospital
- Nami Yamashita, Associate Surgeon, Breast Oncology Center, Breast Surgical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research
Observers in the Mansfield-PhRMA program are selected and funded by their respective agencies. The 2023 program observers are:
- Juyoung Park, Deputy Manager, Division of Research Programs, Department of International Strategy, Japan Agency for Medical Research and Development (AMED)
- Masaki Kasai, Deputy Review Director, Office of Pharmacovigilance II, the Pharmaceutical and Medical Devices Agency (PMDA)
- Takeya Sho, Deputy Director, Bio-Industry Division, Ministry of Economy, Trade and Industry (METI)
The delegation will meet with senior experts in major pharmaceutical research programs, including managers of pharmaceutical research programs in the U.S. government and experts on translating research into commercial opportunities. Upon their return to Japan, the researchers will be expected to share what they learned during the program with their Japanese colleagues and to contribute to Japan’s research and development (R&D) policy reforms in a practical way.